Cefetamet

{{Drugbox | IUPAC_name = (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-
2-methoxyiminoacetyl]amino]-3-methyl-8-oxo-
5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | image = cefetamet.png | CAS_number = | ATC_prefix = J01 | ATC_suffix = DD10 | PubChem = 5487888 | DrugBank = | C=14|H=15|N=5|O=5|S=2 | molecular_weight = 397.432 g/mol | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | pregnancy_AU = | pregnancy_US = | pregnancy_category= | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = }}

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]